References and Resources
Semaglutide and Opioid Overdose Risk in Patients With Type 2 Diabetes and Opioid Use Disorder
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations
Efficacy of the GLP-1 receptor agonist, semaglutide
Associations of semaglutide with incidence
and recurrence of alcohol use disorder in
real-world population
The association between glucose-dependent insulinotropic polypeptide and/or glucagon-like peptide-1 receptor agonist prescriptions and substance-related outcomes in patients with
opioid and alcohol use disorders